Uni Eropa - Inggris - EMA (European Medicines Agency)

les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,

Kenya - Inggris - Pharmacy and Poisons Board

les laboratoires servier - france 50 rue carnot 92284 suresnes cedex - france - perindopril arginine/indapamide - tablet - 5/1.25mg - agents acting on the renin-angiotensin system:

Kenya - Inggris - Pharmacy and Poisons Board

les laboratoires servier - france 50 rue carnot - 92284 suresnes cedex - france - gliclazide - tablet - 60 mg - blood glucose lowering drugs excluding insulins:

Kenya - Inggris - Pharmacy and Poisons Board

les laboratoires servier 50, rue carnot – 92284 suresnes cedex - atorvastatin / perindopril arginine - capsule, hard - 40 mg of atorvastatin / 5 mg of perindopril… - combinations of lipid modifying agents: hmg coa

Kenya - Inggris - Pharmacy and Poisons Board

les laboratoires servier - france 50 rue carnot 92284 suresnes cedex - france - ivabradine - tablet - 5 mg - other cardiac preparations

Kenya - Inggris - Pharmacy and Poisons Board

les laboratoires servier - france 50 rue carnot - 92284 suresnes cedex - france - ivabradine - tablet - 7.5 mg - other cardiac preparations

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

les laboratoires servier - atorvastatin; perindopril arginine; amlodipine - film-coated tablet - 10 mg/5 mg/5 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz atorvastatin, amlodipine and perindopril - : lipid modifying agents, hmg coa reductase inhibitors, other combinations - triveram is indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolaemia or mixed hyperlipidaemia, as substitution therapy in adult patients adequately controlled with atorvastatin, perindopril and amlodipine given concurrently at the same dose level as in the combination.

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

les laboratoires servier - atorvastatin; perindopril arginine; amlodipine - film-coated tablet - 20 mg/5 mg/5 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz atorvastatin, amlodipine and perindopril - : lipid modifying agents, hmg coa reductase inhibitors, other combinations - triveram is indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolaemia or mixed hyperlipidaemia, as substitution therapy in adult patients adequately controlled with atorvastatin, perindopril and amlodipine given concurrently at the same dose level as in the combination.

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

les laboratoires servier - atorvastatin; perindopril arginine; amlodipine - film-coated tablet - 20 mg/10 mg/5 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz atorvastatin, amlodipine and perindopril - : lipid modifying agents, hmg coa reductase inhibitors, other combinations - triveram is indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolaemia or mixed hyperlipidaemia, as substitution therapy in adult patients adequately controlled with atorvastatin, perindopril and amlodipine given concurrently at the same dose level as in the combination.

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

les laboratoires servier - atorvastatin; perindopril arginine; amlodipine - film-coated tablet - 20 mg/10 mg/10 milligram(s) - hmg coa reductase inhibitors, other combinations; zzz atorvastatin, amlodipine and perindopril - lipid modifying agents, hmg coa reductase inhibitors, other combinations - triveram is indicated for the treatment of essential hypertension and/or stable coronary artery disease, in association with primary hypercholesterolaemia or mixed hyperlipidaemia, as substitution therapy in adult patients adequately controlled with atorvastatin, perindopril and amlodipine given concurrently at the same dose level as in the combination